[Hairy cell leukemia with specific omental involvement]. 1996

M A Volkova, and S V Lepkov, and A N Nechipaĭ, and N A Probatova, and N N Tupitsin, and E N Sholokhova, and N V Lebedeva, and M A Frenkel'

UI MeSH Term Description Entries
D007943 Leukemia, Hairy Cell A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of "hairy" or "flagellated" cells in the blood and bone marrow. Hairy Cell Leukemia,Leukemic Reticuloendotheliosis,Reticuloendotheliosis, Leukemic,Hairy Cell Leukemias,Leukemias, Hairy Cell,Leukemic Reticuloendothelioses,Reticuloendothelioses, Leukemic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009852 Omentum A double-layered fold of peritoneum that attaches the STOMACH to other organs in the ABDOMINAL CAVITY. Omentums
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015649 Pentostatin A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity. 2'-Deoxycoformycin,CI-825,Co-Vidarabine,Deoxycoformycin,Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-,NSC-218321,Nipent,2' Deoxycoformycin,CI 825,CI825,NSC 218321,NSC218321
D016898 Interferon-alpha One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways. Interferon Alfa,Interferon, Leukocyte,Interferon, Lymphoblast,alpha-Interferon,IFN-alpha D,IFN-alpha5,Interferon alpha-1,Interferon alpha-17,Interferon alpha-4,Interferon alpha-5,Interferon alpha-7,Interferon alpha-88,Interferon alpha-J,Interferon alpha-T,Interferon alpha4,Interferon alpha5,Interferon, Lymphoblastoid,Interferon, alpha,LeIF I,LeIF J,Leif D,IFN alpha D,IFN alpha5,Interferon alpha,Interferon alpha 1,Interferon alpha 17,Interferon alpha 4,Interferon alpha 5,Interferon alpha 7,Interferon alpha 88,Interferon alpha J,Interferon alpha T,Leukocyte Interferon,Lymphoblast Interferon,Lymphoblastoid Interferon,alpha Interferon

Related Publications

M A Volkova, and S V Lepkov, and A N Nechipaĭ, and N A Probatova, and N N Tupitsin, and E N Sholokhova, and N V Lebedeva, and M A Frenkel'
April 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
M A Volkova, and S V Lepkov, and A N Nechipaĭ, and N A Probatova, and N N Tupitsin, and E N Sholokhova, and N V Lebedeva, and M A Frenkel'
April 1982, Cancer,
M A Volkova, and S V Lepkov, and A N Nechipaĭ, and N A Probatova, and N N Tupitsin, and E N Sholokhova, and N V Lebedeva, and M A Frenkel'
February 1983, The American journal of medicine,
M A Volkova, and S V Lepkov, and A N Nechipaĭ, and N A Probatova, and N N Tupitsin, and E N Sholokhova, and N V Lebedeva, and M A Frenkel'
April 1983, Cancer,
M A Volkova, and S V Lepkov, and A N Nechipaĭ, and N A Probatova, and N N Tupitsin, and E N Sholokhova, and N V Lebedeva, and M A Frenkel'
August 2018, Clinical case reports,
M A Volkova, and S V Lepkov, and A N Nechipaĭ, and N A Probatova, and N N Tupitsin, and E N Sholokhova, and N V Lebedeva, and M A Frenkel'
January 1988, Skeletal radiology,
M A Volkova, and S V Lepkov, and A N Nechipaĭ, and N A Probatova, and N N Tupitsin, and E N Sholokhova, and N V Lebedeva, and M A Frenkel'
June 1978, Schweizerische medizinische Wochenschrift,
M A Volkova, and S V Lepkov, and A N Nechipaĭ, and N A Probatova, and N N Tupitsin, and E N Sholokhova, and N V Lebedeva, and M A Frenkel'
May 1985, Klinische Wochenschrift,
M A Volkova, and S V Lepkov, and A N Nechipaĭ, and N A Probatova, and N N Tupitsin, and E N Sholokhova, and N V Lebedeva, and M A Frenkel'
November 2002, Leukemia & lymphoma,
M A Volkova, and S V Lepkov, and A N Nechipaĭ, and N A Probatova, and N N Tupitsin, and E N Sholokhova, and N V Lebedeva, and M A Frenkel'
January 1979, The Mount Sinai journal of medicine, New York,
Copied contents to your clipboard!